Ignite Creation Date:
2025-12-24 @ 12:03 PM
Ignite Modification Date:
2026-05-02 @ 9:39 PM
Study NCT ID:
NCT05916261
Status:
RECRUITING
Last Update Posted:
2023-10-26
First Post:
2023-05-23
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Personalized Tumor Vaccines and Pabolizumab in Patients With Advanced Pancreatic Cancer
Sponsor:
Ruijin Hospital
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
2022PCV001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None